These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39312102)

  • 1. AI for BPH Surgical Decision-Making: Cost Effectiveness and Outcomes.
    Lama J; Winograd J; Codelia-Anjum A; Bhojani N; Elterman D; Zorn KC; Chughtai B
    Curr Urol Rep; 2024 Sep; 26(1):4. PubMed ID: 39312102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system.
    Anezaki H; Endo F; Swan G; Takashima K; Rojanasarot S
    J Med Econ; 2024; 27(1):554-565. PubMed ID: 38466193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of artificial intelligence, machine learning and deep learning models in corneal disorders - A narrative review.
    Gurnani B; Kaur K; Lalgudi VG; Kundu G; Mimouni M; Liu H; Jhanji V; Prakash G; Roy AS; Shetty R; Gurav JS
    J Fr Ophtalmol; 2024 Sep; 47(7):104242. PubMed ID: 39013268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.
    Pinton P
    Ann Med; 2023; 55(2):2300670. PubMed ID: 38163336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tribulations and future opportunities for artificial intelligence in precision medicine.
    Carini C; Seyhan AA
    J Transl Med; 2024 Apr; 22(1):411. PubMed ID: 38702711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence, the Digital Surgeon: Unravelling Its Emerging Footprint in Healthcare - The Narrative Review.
    Shang Z; Chauhan V; Devi K; Patil S
    J Multidiscip Healthc; 2024; 17():4011-4022. PubMed ID: 39165254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.
    Gill BC; Ulchaker JC
    Curr Urol Rep; 2018 Jul; 19(9):72. PubMed ID: 30022307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.
    Ohsfeldt RL; Kreder KJ; Klein RW; Chrischilles EA
    J Manag Care Pharm; 2004; 10(5):412-22. PubMed ID: 15369424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.
    Plosker GL; Goa KL
    Pharmacoeconomics; 1997 Feb; 11(2):184-97. PubMed ID: 10165827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Pharmacoeconomics; 2006; 24(2):171-91. PubMed ID: 16460137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
    Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
    Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study.
    Glaser AP; Smith AR; Maglaque D; Helfand BT; Mohamed R; An H; Marquez M; Talaty P; Carolan P; Geller AM; Farina FR; Jensen SE; Griffith JW
    BMC Urol; 2024 May; 24(1):110. PubMed ID: 38773430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence and Machine Learning in Rotator Cuff Tears.
    Rodriguez HC; Rust B; Hansen PY; Maffulli N; Gupta M; Potty AG; Gupta A
    Sports Med Arthrosc Rev; 2023 Sep; 31(3):67-72. PubMed ID: 37976127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling.
    Kale M; Wankhede N; Pawar R; Ballal S; Kumawat R; Goswami M; Khalid M; Taksande B; Upaganlawar A; Umekar M; Kopalli SR; Koppula S
    Ageing Res Rev; 2024 Sep; 101():102497. PubMed ID: 39293530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision aids for benign prostatic hyperplasia and prostate cancer.
    Arterburn D; Wellman R; Westbrook EO; Ross TR; McCulloch D; Handley M; Lowe M; Cable C; Zeliadt SB; Hoffman RM
    Am J Manag Care; 2015 Feb; 21(2):e130-40. PubMed ID: 25880488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions.
    Almusafer M; Narayan Y; Nnorom I; Karna S; Katsouri A; Russo GI; Morgado A; Symeonidis EN; Buchholz N; Papatsoris A; Tsampoukas G
    Expert Opin Pharmacother; 2024 May; 25(7):907-914. PubMed ID: 38828638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.
    Di Silverio F; D'Eramo G; Flammia GP; Sciarra A; Buscarini M; Mauro M; Sciarra F
    Minerva Urol Nefrol; 1994 Jun; 46(2):93-9. PubMed ID: 7526475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.